Whalegun
Home

Sujal Shah, CEO: CymaBay Therapeutics CBAY Sell · Filed 23/10/10

Trade details

Type
Insider sale
Amount
$921,026.2
Shares · price
64,861 sh · $14.20 a share
Held after
171,301 sh
Stock
CymaBay Therapeutics CBAY
Person
Sujal ShahCEO
Trade date
23/10/09
Filed
23/10/10
Days to filing
1 days

Sold 27.5% of holdings

Share of holding sold
27.5%

CymaBay Therapeutics trades, last 26 weeks

What else happened in CymaBay Therapeutics around then

Filed or reported within 30 days of the trade day · 23/09/09~23/11/08

Sujal Shah's recent trades

  • Sujal Shah

    Sell10b5-1 planCymaBay Therapeutics

    $1.3M

    Filed 23/12/11

  • Sujal Shah

    Sell10b5-1 planCymaBay Therapeutics

    $18.5K

    Filed 23/12/11

  • Sujal Shah

    Sell10b5-1 planCymaBay Therapeutics

    $699.3K

    Filed 23/11/14

  • Sujal Shah

    Sell10b5-1 planCymaBay Therapeutics

    $331.4K

    Filed 23/11/14

Sujal Shah, CEO — sold $921K of CymaBay Therapeutics CBAY · 27.5% of holdings · 10b5-1 plan | Whalegun